The checkpoints of viral gene expression in productive and latent infection: The role of the HDAC/CoREST/LSD1/REST repressor complex

Journal of Virology

Volumn 85, Issue 15, 2011, Pages 7474-7482

  Roizman, Bernard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COREPRESSOR OF REPRESSOR ELEMENT 1 SILENCING TRANSCRIPTION; COREPRESSOR PROTEIN; HISTONE DEACETYLASE; INFECTED CELL PROTEIN 0; LYSINE SPECIFIC DEMETHYLASE 1; MICRORNA; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; COMPLEX FORMATION; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE SILENCING; HERPES SIMPLEX VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SPINAL GANGLION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENE; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HERPES SIMPLEX; HISTONE DEACETYLASES; HUMANS; TRANSCRIPTION FACTORS;

SIMPLEXVIRUS;

EID: 79960427728     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00180-11     Document Type: Article

References (93)

1. Ahmed, M., M. Lock, C. Miller, and N. Fraser. 2002. Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J. Virol. 76:717-729.
2. Amelio, A., N. Giordani, N. Kubat, J. O'Neil, and D. C. Bloom. 2006. Deacetylation of the herpes simplex virus type 1 latency-associated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICP0 transcriptional permissiveness at early times postexplant. J. Virol. 80:2063-2068.
3. Ballas, N., and G. Mandel. 2005. The many faces of REST oversee epigenetic programming of neuronal genes. Curr. Opin. Neurobiol. 15:500-506.
4. Boutell, C., S. Sadis, and R. D. Everett. 2002. Herpes simplex virus type 1 immediate-early protein ICP0 and its isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76:841-850.
5. Cai, W., and P. A. Schaffer. 1992. Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J. Virol. 66:2904-2915.
6. Canning, M., C. Boutell, J. Parkinson, and R. D. Everett. 2004. A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7. J. Biol. Chem. 279:38160-38168.
7. Chee, A. V., P. Lopez, P. P. Pandolfi, and B. Roizman. 2003. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77:7101-7105.
8. Chen, J., C. Panagiotidis, and S. Silverstein. 1992. Multimerization of ICP0, a herpes simplex virus immediate-early protein. J. Virol. 66:5598-5602.
9. Chen, S., et al. 2002. Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICP0 transcripts in mouse ganglia latently infected with herpes simplex virus. J. Virol. 76:4764-4772.
10. Cliffe, A. R., D. A. Garber, and D. M. Knipe. 2009. Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J. Virol. 83:8182-8190.
11. Cliffe, A. R., and D. M. Knipe. 2008. Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection. J. Virol. 82:12030-12038.
12. Cui, C., et al. 2006. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 80:5499-5508.
13. Danaher, R., et al. 2005. Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. J. Neurovirol. 11:306-317.
14. Deatly, A. M., J. G. Spivack, E. Lavi, and N. W. Fraser. 1987. RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc. Natl. Acad. Sci. U. S. A. 84:3204-3208.
15. DeLuca, N. 2011. Functions and mechanism of action of the herpes simplex virus regulatory protein ICP4, p. 17-38. In S. K. Weller (ed.), Alphaherpesviruses, molecular virology. Caister Academic Press, Norfolk, United Kingdom.
16. Doucas, V., M. Tini, D. A. Egan, and R. M. Evans. 1999. Modulation of CREB binding protein function by promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. U. S. A. 96:2627-2632.
17. Du, T., G. Zhou, S. Khan, H. Gu, and B. Roizman. 2010. Disruption of HDAC/CoREST/REST repressor by dnREST reduces genome silencing and increases virulence of herpes simplex virus. Proc. Natl. Acad. Sci. U. S. A. 107:15904-15909.
18. Everett, R. D., et al. 1997. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16:566-577.
19. Everett, R. D., M. Meredith, and A. Orr. 1999. The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication. J. Virol. 73:417-426.
20. Everett, R. D., and J. Murray. 2005. ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 79:5078-5089.
21. Farrell, M. J., A. T. Dobson, and L. T. Feldman. 1991. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. U. S. A. 88:790-794.
22. Feldman, L. T., et al. 2002. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. U. S. A. 99:978-983.
23. Gopalakrishnan, V. 2009. REST and the RESTless: in stem cells and beyond. Future Neurol. 4:317-329.
24. Gu, H., Y. Liang, G. Mandel, and B. Roizman. 2005. Components of the REST/CoREST/histone deacetylase repressor are disrupted, modified and translocated in HSV-1-infected cells. Proc. Natl. Acad. Sci. U. S. A. 102: 7571-7576.
25. Gu, H., A. P. Poon, and B. Roizman. 2009. During its nuclear phase the multifunctional regulatory protein ICP0 undergoes proteolytic cleavage characteristic of polyproteins. Proc. Natl. Acad. Sci. U. S. A. 106:19132-19137.
26. Gu, H., and B. Roizman. 2003. The degradation of PML and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc. Natl. Acad. Sci. U. S. A. 100:8963-8968.
27. Gu, H., and B. Roizman. 2009. The two functions of HSV-1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem. J. Virol. 83:181-187.
28. Gu, H., and B. Roizman. 2007. Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST/REST complex. Proc. Natl. Acad. Sci. U. S. A. 104:17134-17139.
29. Hagglund, R., C. Van Sant, P. Lopez, and B. Roizman. 2002. Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. U. S. A. 99:631-666.
30. Hill, T., W. Blyth, and D. Harbour. 1978. Trauma to the skin causes recurrence of herpes simplex in the mouse. J. Gen. Virol. 39:21-28.
31. Honess, R. W., and B. Roizman. 1975. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:8-19.
32. Honess, R. W., and B. Roizman. 1975. Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc. Natl. Acad. Sci. U. S. A. 72:1276-1280.
33. Ishov, A. M., and G. Maul. 1996. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J. Cell Biol. 134:815-826.
34. Jarman, R. G., E. K. Wagner, and D. C. Bloom. 1999. LAT expression during acute HSV infection in the mouse. Virology 262:384-397.
35. Javier, R., J. Stevens, V. Dessette, and E. Wagner. 1988. A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology 166:254-257.
36. Johnson, D. S., A. Mortazavi, R. M. Myers, and B. Wold. 2007. Genomewide mapping of in vivo protein-DNA interactions. Science 316:1497-1502.
37. Jothi, R., S. Cuddapah, A. Barski, K. Cui, and K. Zhao. 2008. Genome-wide identification of in vivo protein-DNA binding sites from ChIP-Seq data. Nucleic Acids Res. 36:5221-5231.
38. Kalamvoki, M., and B. Roizman. 2008. Nuclear retention of ICP0 in cells exposed to HDAC inhibitor or transfected with DNA before infection with herpes simplex virus 1. Proc. Natl. Acad. Sci. U. S. A. 105:20488-20493.
39. Kalamvoki, M., and B. Roizman. 2009. ICP0 enables and monitors the function of D cyclins in herpes simplex virus 1 infected cells. Proc. Natl. Acad. Sci. U. S. A. 106:14576-14580.
40. Kalamvoki, M., and B. Roizman. 2010. The interwoven roles of cyclin D3 and CDK4 recruited by ICP0 and ICP4 in the expression of herpes simplex virus genes. J. Virol. 84:9709-9717.
41. Kalamvoki, M., and B. Roizman. 2010. The circadian CLOCK histone acetyl transferase localizes at ND10 nuclear bodies and enables herpes simplex virus genes expression. Proc. Natl. Acad. Sci. U. S. A. 107:17721-17726.
42. Kalamvoki, M., and B. Roizman. 2010. The role of herpes simplex virus ICP0 in the transactivation of genes introduced by infection or transfection: a reappraisal. J. Virol. 84:4222-4228.
43. Kawaguchi, Y., et al. 2001. Herpes simplex virus 1 α regulatory protein ICP0 functionally interacts with cellular transcription factor BMAL1. Proc. Natl. Acad. Sci. U. S. A. 98:1877-1882.
44. Kawaguchi, Y., C. Van Sant, and B. Roizman. 1997. Herpes simplex virus 1 α regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J. Virol. 71:7328-7336.
45. Knipe, D. M., and A. R. Cliffe. 2008. Chromatin control of herpes simplex virus lytic and latent infection. Nat. Rev. Microbiol. 6:211-221.
46. Kristie, T. M., J. L. Vogel, and A. E. Sears. 1999. Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc. Natl. Acad. Sci. 96:1229-1233.
47. Kutluay, S. B., and S. J. Triezenberg. 2009. Regulation of histone deposition on the herpes simplex virus type 1 genome during lytic infection. J. Virol. 83:5835-5845.
48. Kwiatkowski, D., H. Thompson, and D. C. Bloom. 2009. The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency. J. Virol. 83:8173-8181.
49. La Boissie're, S., T. Hughes, and P. O'Hare. 1999. HCF-dependent nuclear import of VP16. EMBO J. 18:480-489.
50. Lacasse, J. J., and L. M. Schang. 2010. During lytic infections, herpes simplex virus type 1 is in complexes with properties of unstable nucleosomes. J. Virol. 84:1920-1933.
51. Lagunoff, M., G. Randall, and B. Roizman. 1996. Phenotypic properties of herpes simplex virus 1 containing a derepressed ORF P gene. J. Virol. 70:1810-1817.
52. Lee, M. G., C. Wynder, N. Cooch, and R. Shiekhattar. 2005. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437: 432-435.
53. Leopardi, R., N. Michael, and B. Roizman. 1995. Repression of the herpes simplex virus 1 α4 gene by its gene product (ICP4) within the context of the viral genome is conditioned by the distance and stereoaxial alignment of the ICP4 DNA binding site relative to the TATA box. J. Virol. 69:3042-3048.
54. Liang, Y., J. L. Vogel, A. Narayanan, H. Peng, and T. M. Kristie. 2009. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat. Med. 15:1312-1317.
55. Lopez, P., R. J. Jacob, and B. Roizman. 2002. Overexpression of promyelocytic leukemia protein (PML) precludes the dispersal of ND10 structures and has no effect on the accumulation of infectious herpes simplex virus 1 or its proteins. J. Virol. 76:9355-9367.
56. Lopez, P., C. Van Sant, and B. Roizman. 2001. Requirements for the nuclear-cytoplasmic translocation of infected cell protein 0 of herpes simplex virus 1. J. Virol. 75:3832-3840.
57. Mackem, S., and B. Roizman. 1982. Structural features of the herpes simplex virus α gene 4, 0, and 27 promoter-regulatory sequences which confer α regulation on chimeric thymidine kinase gene. J. Virol. 44:939-949.
58. Maillet, S., et al. 2006. Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts. J. Virol. 80: 9310-9321.
59. Maul, G. G., D. Negorev, P. Bell, and A. M. Ishov. 2000. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129:278-287.
60. Metzger, E., et al. 2005. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437:436-439.
61. Michael, N., D. Spector, P. Mavromara-Nazos, T. M. Kristie, and B. Roizman. 1988. The DNA-binding properties of the major regulatory protein α4 of herpes simplex viruses. Science 239:1531-1534.
62. Mitchell, W., R. Lirette, and N. Fraser. 1990. Mapping of low abundance latency-associated RNA in the trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J. Gen. Virol. 71:125-132.
63. Narayanan, A., M. L. Nogueira, W. T. Ruyechan, and T. M. Kristie. 2005. Combinatorial transcription of herpes simplex virus and varicella zoster virus immediate early genes is strictly determined by the cellular co-activator HCF-1. J. Biol. Chem. 280:1369-1375.
64. Negorev, D., and G. G. Maul. 2001. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20:7234-7242.
65. Neumann, D., P. Bhattacharjee, and J. Hill. 2007. Sodium butyrate: a chemical inducer of in vivo reactivation herpes simplex virus type 1 in the ocular mouse model. J. Virol. 81:6106-6110.
66. Neumann, D., P. Bhattacharkee, N. Ciodani, D. C. Bloom, and J. Hill. 2007. In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment. J. Virol. 81:13248-13253.
67. Otto, S. J., et al. 2007. A new binding motif for the transcriptional repressor RET uncovers large networks devoted to neuronal functions. J. Neurosci. 27:6729-6739.
68. Poon, A. P., H. Gu, and B. Roizman. 2006. ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc. Natl. Acad. Sci. U. S. A. 103:9993-9998.
69. Poon, A. P., Y. Liang, and B. Roizman. 2003. Herpes simplex virus 1 gene expression is accelerated by inhibitors of histone deacetylases in rabbit skin cells infected with a mutant carrying a cDNA copy of the infected-cell protein no. 0. J. Virol. 77:12671-12678.
70. Randall, G., M. Lagunoff, and B. Roizman. 1997. The product of ORF O located within the domain of herpes simplex virus 1 genome transcribed during latent infection binds to and inhibits in vitro binding of ICP4 to its cognate DNA site. Proc. Natl. Acad. Sci. U. S. A. 94:10379-10384.
71. Randall, G., and B. Roizman. 1997. Transcription of the derepressed open reading frame P of herpes simplex virus 1 precludes the expression of the antisense α134.5 gene and may account for the attenuation of the mutant virus. J. Virol. 71:7750-7757.
72. Roizman, B., D. M. Knipe, and R. J. Whitley. 2007. Herpes simplex viruses, p. 2501-2601. In D. M. Knipe et al. (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, New York, NY.
73. Roizman, B., and A. E. Sears. 1987. An inquiry into the mechanism of herpes simplex virus latency. Annu. Rev. Microbiol. 41:543-571.
74. Roizman, B., and J. R. Whitley. 2001. The nine ages of herpes simplex viruses. Herpes 8:23-26.
75. Sawtell, N. M. 1997. Comprehensive quantification of herpes simplex virus latency at the single-cell level. J. Virol. 71:5423-5431.
76. Shi, Y. J., C. Matson, S. Iwase, T. Baba, and Y. Shi. 2005. Regulation of LSD1 histone demethylase activity by its associated factors. Mol. Cell 19: 857-864.
77. Spivack, J., and N. Fraser. 1987. Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J. Virol. 61:3841-3847.
78. Spivack, J., G. Woods, and N. Fraser. 1991. Identification of a novel latencyspecific splice donor signal within the herpes simplex virus type 1 2.0-kilobase latency-associated transcript (LAT): translation inhibition of LAT open reading frames by the intron within the 2.0-kilobase LAT. J. Virol. 65:6800-6810.
79. Stevens, J. G., E. K. Wagner, G. B. Devi-Rao, M. L. Cook, and L. T. Feldman. 1987. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235:1056-1059.
80. Tang, S., et al. 2008. An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proc. Natl. Acad. Sci. U. S. A. 105:10931-10936.
81. Tapia-Ramírez, J., B. J. Eggen, M. J. Peral-Rubio, J. J. Toledo-Aral, and G. Mandel. 1997. A single zinc finger motif in the silencing factor REST represses the neural-specific type II sodium channel promoter. Proc. Natl. Acad. Sci. U. S. A. 94:1177-1182.
82. Thomas, S., C. Lilley, D. Latchman, and R. Coffin. 2002. A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome. J. Virol. 76:4056-5067.
83. Thompson, R. L., C. M. Preston, and N. M. Sawtell. 2009. De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. PLoS Pathog. 5:e1000352.
84. Thompson, R. L., and N. M. Sawtell. 2000. HSV latency-associated transcript and neuronal apoptosis. Science 289:1651.
85. Thompson, R. L., and N. M. Sawtell. 2001. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J. Virol. 75: 6660-6675.
86. Tsai, M. C., et al. 2010. Long noncoding RNA as modular scaffolds of histone modification complexes. Science 329:689-693.
87. Umbach, J. L., et al. 2008. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454:780-783.
88. Umbach, J. L., M. Nagel, R. Cohrs, D. Gilden, and B. R. Cullen. 2009. Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia. J. Virol. 83:10677-10683.
89. Wang, K., L. Pesnicka, E. Guancial, P. Krause, and S. Straus. 2001. The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice. J. Virol. 75:8166-8172.
90. Wang, Q.-Y., et al. 2005. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc. Natl. Acad. Sci. U. S. A. 102:16055-16059.
91. Wu, T., Y. Su, T. Block, and J. Taylor. 1996. Evidence that two latencyassociated transcripts of herpes simplex virus type 1 are nonlinear. J. Virol. 70:5962-5967.
92. Yang, M., et al. 2006. Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. Mol. Cell 23:377-387.
93. Zhou, G., T. Du, and B. Roizman. 2010. The CoREST/REST repressor is both necessary and inimical for expression of herpes simplex virus gene expression. mBio 2:e00313-10.